Trial Profile
Clinical Study of Anlotinib in Maintenance Treatment of Advanced NSCLC
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 14 Dec 2018
At a glance
- Drugs Anlotinib (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Acronyms CSOAIMTOAN
- 14 Dec 2018 New trial record